Nu-Med Plus (NUMD) Enterprise Value Growth (1y) (2012 - 2025)
Nu-Med Plus (NUMD) Enterprise Value Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72.14% |
| Sep 30, 2025 | 51.79% |
| Jun 30, 2025 | 78.64% |
| Mar 31, 2025 | 62.67% |
| Dec 31, 2024 | 65.13% |
| Sep 30, 2024 | 63.56% |
| Jun 30, 2024 | 86.51% |
| Mar 31, 2024 | 88.01% |
| Dec 31, 2023 | 90.70% |
| Sep 30, 2023 | -1,665.61% |
| Mar 31, 2023 | -1,990.22% |
| Dec 31, 2022 | -526.94% |
| Sep 30, 2022 | 98.03% |
| Mar 31, 2022 | 98.18% |
| Dec 31, 2021 | 93.81% |
| Sep 30, 2021 | -1.09% |
| Jun 30, 2021 | -1,092.78% |
| Mar 31, 2021 | -659.85% |
| Dec 31, 2020 | -2,562.89% |
| Sep 30, 2020 | 24.71% |